• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Moximed

Moximed’s ‘shock absorber for the knee’ trial begins

January 8, 2019 By Nancy Crotti

  Moximed said that surgeons have implanted its Calpyso knee unloading system in the first osteoarthritis patient in its U.S. clinical trial. The Calypso is designed to work like a shock absorber for the knee by restoring a more normal load balance within the joint. It may help prevent or delay total knee replacement, according to […]

Filed Under: Clinical Trials, Implants, News Well, Orthopedics, Research & Development, Surgical Tagged With: Moximed, Wexner Medical Center

These medtech companies raised the most VC last year

January 19, 2018 By Danielle Kirsh

Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving […]

Filed Under: Cardiovascular, Digital Health, Funding Roundup, Hospital Care, Implants Tagged With: Auris Surgical Robotics, Cereve, EarLens, Ebb Therapeutics, EBR Systems Inc., Epix Therapeutics (formerly Advanced Cardiac Therapeutics), Fractyl Laboratories, immusant, MedTech, Moximed, NeuroPace, Outset Medical, Pulmonx, Respicardia, rxsight, Silk Road Medical Inc., venture capital, VertiFlex Inc., Xenex

Moximed closes $50m Series C

March 16, 2017 By Fink Densford

California orthopedic device developer Moximed said today it raised $50 million in a Series C round of financing. The round was joined by newly invested Advent Life Sciences and Future fund and existing investors NEA, Morgenthaler Ventures, Gilde Healthcare, GBS Venture Partners and Vertex Healthcare. “This financing round is timely, as we are completing the primary […]

Filed Under: Business/Financial News, Orthopedics Tagged With: Moximed

Moximed launches IDE trial of Atlas unicompartmental knee

November 29, 2016 By Fink Densford

California orthopedic device developer Moximed said today it enrolled the 1st patient in an FDA approved investigational device exemption trial of its next-gen Atlas unicompartmental unloading knee implant. The Atlas is designed to treat osteoarthritis knee joint pain in patients ages 35 to 65 whose condition has not degenerated enough to require arthroplasty. The device is a joint unloader […]

Filed Under: Clinical Trials, Orthopedics Tagged With: Moximed

CE Mark in hand, Moximed hatches U.S. approval strategy for knee stabilization implant

December 14, 2015 By Mark Hollmer

The knee replacement market has reached stratospheric levels in the U.S., with competitors ranging from Zimmer Biomet (NYSE:ZBH) to Smith & Nephew (NYSE:SNN) and Johnson & Johnson (NYSE:JNJ). California device developer Moximed is betting its future, however, on patients not quite ready for the drastic surgery. The knee replacement market is worth an estimated $4 billion […]

Filed Under: Clinical Trials, Orthopedics, Regulatory/Compliance Tagged With: Knees, Moximed

Moximed wins CE Mark for Atlas ‘shock absorbing’ knee

November 25, 2015 By Fink Densford

Moximed said last week it won CE Mark approval in the European Union for its Atlas ‘shock absorber’ knee joint unloader for pre-arthroplasty patients. The Atlas system is an implantable joint unloader placed subcutaneously along the knee joint to absorb excess joint load rather than transfer it to healthy areas of the joint, the Hayward, […]

Filed Under: Orthopedics, Regulatory/Compliance Tagged With: Moximed

Moximed springs to $33m Series B round

May 7, 2015 By Brad Perriello Leave a Comment

Moximed springs to $33m

Moximed said today that it pulled in a $33 million Series B round for its KineSpring knee implant, which is designed to reduce the load on the joint while sparing its anatomy.

Filed Under: Funding Roundup, Implants, News Well, Orthopedics Tagged With: GBS Venture Partners, Gilde Healthcare Partners, Knees, Morgenthaler Ventures, Moximed, New Enterprise Associates, Vertex Venture Holdings

Hospital repays $2M to Medicare for unnecessary stenting | MassDevice.com On Call

December 17, 2012 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — A Pennsylvania hospital group associated with more than 140 cases of unnecessary stenting and angioplasties repaid almost $2 million in Medicare reimbursements to the federal government.

The Excela Health network reached an agreement with federal regulators to return the funds, which were collected for heart surgeries performed between 2009 and 2011, according to settlement documents made public this month.

Filed Under: Legal News, Medicare, News Well, Stents Tagged With: Moximed, On Call

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS